TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2022

Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study.

Ian E Krop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.